Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
25.02.26
/
50%
€162.75
Target price
25.02.27
€212.10
Performance (%)
17.79%
Price
08.05.26
€191.70
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan currently has a performance of 17.79%. This prediction currently runs until 25.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 10.841% | 10.841% |
| iShares Core DAX® | 0.224% | 1.487% |
| iShares Nasdaq 100 | 6.047% | 16.188% |
| iShares Nikkei 225® | 5.724% | 11.690% |
| iShares S&P 500 | 2.172% | 8.056% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $235.00 to $250.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€192.05
06.05.26
06.05.26
€226.10
06.05.27
06.05.27
-0.18%
08.05.26
08.05.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€155.95
18.11.25
18.11.25
€202.73
18.11.26
18.11.26
22.92%
08.05.26
08.05.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.00
13.02.25
13.02.25
€163.54
13.02.26
13.02.26
6.50%
14.02.26
14.02.26